Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Corticosteroid therapy for sarcoidosis].

Keiko Hiyama1

  • 1Department of Molecular and Internal Medicine, Division of Clinical Medical Science, Programs for Applied Biomedicine, Hiroshima University Graduate School of Biomedical Sciences.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 18, 2002
PubMed
Summary

Corticosteroid therapy for sarcoidosis lacks established protocols despite 50 years of use. Current consensus indicates systemic corticosteroids for severe, symptomatic, or progressive sarcoidosis cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unique Function in Cancer Stemness and Prognostic Significance of <i>EMX2</i> in Esophageal Squamous Cell Carcinoma.

Biomedicines·2025
Same author

Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions.

PloS one·2018
Same author

The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.

PloS one·2015
Same author

Clinical features of ATRX or DAXX mutated neuroblastoma.

Journal of pediatric surgery·2014
Same author

Association of EPAS1 gene rs4953354 polymorphism with susceptibility to lung adenocarcinoma in female Japanese non-smokers.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2014
Same author

Positive action is required to achieve the 2020.30 goal of gender equality in Japanese medical societies.

Surgery today·2013

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Rheumatology

Context:

  • Sarcoidosis treatment remains challenging due to variable disease course and lack of predictive markers.
  • Fifty years of corticosteroid use have not yielded definitive treatment guidelines for sarcoidosis.
  • Concerns include spontaneous remission rates, post-treatment relapses, and corticosteroid adverse effects.

Purpose:

  • To review the current consensus and indications for corticosteroid therapy in sarcoidosis.
  • To highlight the controversies and challenges in managing sarcoidosis with corticosteroids.

Summary:

  • No definitive protocol or indication criteria exist for corticosteroid treatment in sarcoidosis.
  • Key indications include systemic and symptomatic disease, such as cardiac, neurologic, and ocular involvement, and progressive pulmonary disease.

Related Experiment Videos

  • Controversies stem from spontaneous remission, relapse rates, lack of predictive markers, and corticosteroid side effects.

    • Impact:

    • Informs clinical decision-making for sarcoidosis management.
    • Highlights the need for further research into evidence-based treatment strategies.
    • Aims to optimize patient outcomes while minimizing corticosteroid-related morbidity.